Pilot [prog]
Double-Blind Study [resa]
randomized [resa]
placebo-controlled [resa]
Molsidomin [orch, phsu]
mg% [qnco]
Patients [podg]
Suffering [mobd]
Angina Pectoris, Stable [dsyn]
Correlation [qlco]
Efficacy [qlco]
plasma concentration [qnco]
objectives [inpr]
o a [dsyn]
Formulation [resa]
Molsidomin [orch, phsu]
mg% [qnco]
Evaluated [ftcn]
Patients [podg]
Angina Pectoris, Stable [dsyn]
Aims [idcn]
Pharmacokinetics [phsf]
Single [popg]
Dose [qnco]
Efficacy [qlco]
Safety [hcpp]
placebo [topp]
investigate [ftcn]
Correlation [qlco]
Pharmacokinetics [phsf]
pharmacodynamics [ftcn]
Methods [inpr]
Patients [podg]
DOUBLE BLIND [resa]
cross over [genf]
randomized controlled trial [inpr, resa]
placebo [topp]
Pharmacokinetics [phsf]
Molsidomin [orch, phsu]
sin [idcn]
Active [ftcn]
Metabolite [bacs]
Specific [qlco]
Time Point [tmco]
Administration [ocac]
Single [popg]
Dose [qnco]
Molsidomin [orch, phsu]
mg/d [qnco]
Patients [podg]
Distributed [ftcn]
Seven [qnco]
Group [idcn]
twenty [orch, phsu]
Eight [qnco]
Patients [podg]
baseline [bodm]
Exercise Test [diap]
Response [orga]
Run-in Period [tmco]
placebo [topp]
Efficacy [qlco]
Molsidomin [orch, phsu]
placebo [topp]
Relationships [qlco]
plasma concentration [qnco]
Molsidomin [orch, phsu]
sin [idcn]
Ischaemic [ftcn]
Threshold [qlco]
Assessed [acty]
Patients [podg]
Exercise Test [diap]
baseline [bodm]
Variable [qlco]
Ischaemia [dsyn]
Limited [ftcn]
Tolerance [fndg]
Exercise [dora]
Evaluated [ftcn]
Patients [podg]
exercise induced [sosy]
Ischaemia [dsyn]
Molsidomin [orch, phsu]
mg/d [qnco]
PHARMACOKINETIC [resa]
pharmacodynamic [biof]
Relationships [qlco]
Evaluated [ftcn]
Regression [patf]
Models [inpr]
Correlation [qlco]
Highest [qlco]
Average Concentration [qnco]
Molsidomin [orch, phsu]
sin [idcn]
Occurred [acty]
H+ [elii]
Then [tmco]
Plateau [qnco]
Molsidomin [orch, phsu]
sin [idcn]
Maintained [ftcn]
H+ [elii]
Residual [qlco]
Molsidomin [orch, phsu]
Concentration [menp]
H+ [elii]
Post [tmco]
Drug [phsu]
Intake [ftcn]
effective [qlco]
Range [qnco]
Work Load [qnco]
P NOS [aapp, imft]
Total exercise time [tmco]
P NOS [aapp, imft]
Angina [sosy]
P NOS [aapp, imft]
0.016" [qnco]
Measured [qlco]
Molsidomin [orch, phsu]
mg/d [qnco]
Relative [famg]
placebo [topp]
Linear Regression [qnco]
Correlation [qlco]
Molsidomin [orch, phsu]
plasma concentration [qnco]
sin [idcn]
Exercise Test [diap]
Improvement [cnce]
R- [spco]
P NOS [aapp, imft]
Work Load [qnco]
R- [spco]
P NOS [aapp, imft]
Total exercise time [tmco]
R- [spco]
P NOS [aapp, imft]
ST segment depression [fndg]
Pharmacokinetics [phsf]
Molsidomin [orch, phsu]
mg% [qnco]
Patients [podg]
Angina Pectoris, Stable [dsyn]
compatible [idcn]
a & d [orch, phsu, vita]
Dosage [qnco]
Regimen [topp]
Formulation [resa]
effective [qlco]
Well [qlco]
H+ [elii]
Therapeutic [topp]
myocardial ischaemia [dsyn]
Linear [spco]
Relationship [qlco]
Molsidomin [orch, phsu]
plasma concentration [qnco]
Exercise Tolerance [clna]
Observed [ftcn]
